Surging venture financing and strategic partnerships in 2025 are fueling next-phase therapeutic development in veterinary oncology, underscoring robust business growth in companion animal health. Notably, biopharma firms dedicated over USD 200 million in R&D funding to canine cancer diagnostics this year. https://livepositively.com/veterinary-oncology-market-accelerates-amid-rising-pet-cancer-incidence/